Search results
Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
Pharmaceutical Technology via Yahoo Finance· 6 days agoGossamer co-founder, chairman and CEO Faheem Hasnain stated: “This partnership with Chiesi allows us...
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
Benzinga via AOL· 7 days agoThis global collaboration combines the strengths of both Chiesi and Gossamer to support ongoing work...
3 Biotech Stocks to Double Your Money in the Next 24 Months
InvestorPlace via Yahoo Finance· 7 days agoThe biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
AOL· 7 days agoThe therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000 people in the ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoNeurocrine stock is an IBD Tech Leader. Focusing On Treatments For PAH United Therapeutics is now a...
FY2028 Earnings Forecast for Gossamer Bio, Inc. Issued By HC Wainwright (NASDAQ:GOSS)
ETF DAILY NEWS· 5 hours agoGossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Research analysts at HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Gossamer Bio in a report released on Thursday, ...
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Zacks· 3 days agoInsmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
Chiesi buys into Gossamer's Winrevair rival, betting almost $500M
FierceBiotech· 7 days agoItalian pharma Chiesi is betting almost $500 million on Gossamer Bio's pulmonary arterial...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 7 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Liquidia (LQDA) Scheduled to Post Earnings on Tuesday
ETF DAILY NEWS· 1 day agoLiquidia (NASDAQ:LQDA – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, May 14th. Analysts expect the company to announce earnings of ($0.32) per ...